Praxair Remains Neutral Rated - Analyst Blog
January 30 2013 - 8:20AM
Zacks
We currently maintained a Neutral
recommendation on Praxair Inc. (PX) based on its
impressive long-term opportunities, offset by near-term headwinds
surrounding it.
Why Neutral?
The industrial gas producer and
supplier is one of the leading companies having operations in North
and South America, Europe and Asia. Industrial gases are being
increasingly used for various purposes across diverse industries,
including hydrogen for refining; oxygen for healthcare; and
nitrogen and carbon dioxide for oil and gas production.
Demand for Praxair’s products is
ever on the rise with backlog reaching $2.6 billion at the end of
year 2012. This signifies preferences among customers for the
company’s world class technology, high quality products and gas
supply services.
Also, the company remains focused
on developing new products and applications, and innovative
production and distribution techniques. Returning values to
shareholders through dividends and share buybacks is an attractive
feature of the company.
Despite these long-term aspects,
it’s the near-term headwinds that keep us on the sidelines for the
company. Flat revenue in the fourth 2012 as price and acquisition
gains get offset by a negative foreign currency translation, was
disappointing. Geographically, business was weak, especially in
South America and Europe while some signs of strength were
witnessed in Asia and North America.
For the first quarter 2013,
difficult business conditions in European markets, holiday
shutdowns in Asia and Brazil are likely to curtail revenue
generation in these regions. To add to the peril, the company faces
difficulties emanating from negative foreign currency translation
and higher interest and pension expenses.
Near-term concerns and fourth
quarter 2012 results had an impact on earnings estimates for the
company. The Zacks Consensus Estimate for 2013 has gone down by
2.8% to $5.99 (10 of 12 estimates were revised downwards) and for
2014 the estimate has plummeted 1.9% to $6.80 (6 of 13 estimates
were lowered) in the last 7 days.
Others Stocks to Consider
Other stocks to watch out for are
Arkema S.A. (ARKAY) and BASF SE
(BASFY), both holding a Zacks Rank #1 (Strong Buy), and Air
Products & Chemicals Inc. (APD) with a Zacks Rank #2
(Buy).
AIR PRODS & CHE (APD): Free Stock Analysis Report
(ARKAY): ETF Research Reports
BASF SE (BASFY): Free Stock Analysis Report
PRAXAIR INC (PX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Arkema (PK) (USOTC:ARKAY)
Historical Stock Chart
From Dec 2024 to Jan 2025
Arkema (PK) (USOTC:ARKAY)
Historical Stock Chart
From Jan 2024 to Jan 2025